Bench to Boardroom Technology Showcases 2012
For the first time, Bench-to-Boardroom will feature great Technology Showcases profiling the very best technologies from world-class companies.
Domainex and Cresset BioMolecular Discovery’s Joint Technology Showcase
This Technology Showcase will see Domainex and Cresset BioMolecular Discovery discuss the product development time for new medicines and the significant challenge posed when balancing the up-front investment required with the potential return on that investment given the constraints of patent length and generic competition.
10.45 - Drug Discovery in the Year of the Olympics: Smarter, Faster, Cheaper
Trevor Perrior, Research Director, Domainex
11.10 - Computational Chemistry On-demand
Martin Slater, Director of Consulting, Cresset BioMolecular Discovery
11.35 - Facilitated Q & A
11.45 - Close
Kymab, Bicycle Therapeutics and Lonza’s Joint Technology Showcase
This Technology Showcase will see Kymab, Bicycle Therapeutics and Lonza present their leading edge approaches to next generation antibody selection, manufacture and clinical development towards therapeutic and commercial success.
14.15 - Introduction & Welcome
14.20 - Next Generation Human Monoclonal Antibodies
Tom Shepherd, Chief Business Officer, Kymab
14.35 - Combining Advantages of Biologics and NCEs
John Tite, Chief Executive Officer, Bicycle Therapeutics
14.50 - De-risking Protein Therapeutics
Noel Smith, Scientific Leader, Lonza
15.05 - Facilitated Q & A
To view information on any of the presenting companies please click here.